he US based West Pharma has been a major player in providing packaging expertise to major pharmaceutical organizations around the globe. Their forte lies in parenteral preparations, container seals and closures for parenteral formulations, and stability testing of the packaged materials. Since its inception in 1923, West has been actively developing premium, yet pharmaceutically acceptable products and packaging materials for medical devices.
West’s most recent foray has been establishing its presence in India, in the city of Chennai. In June 201, they commenced the set-up of their manufacturing plant in Sri City, which was designed to take care of the global packaging material supply. In order to bring this into effect, they signed a 99 year lease, which gave them access to almost 75000 square metres of land in the Special Economic Zone (SEZ) in Southern India. This came with a plethora of privileges in construction, utility management, labor availability, export and import tax reductions, just to name a few. After the completion of the first phase, which began in August 2012, the unit is now operational and capable of producing metallic and elastomeric seals for parenteral/ injectables. Further construction is currently underway, where a ready-to-sterilize range of components would be manufactured in the first quarter of 2016.
Due to a very central location in the Indian subcontinent, the exports of these pharmaceutical seals to various biopharmaceutical customers in India and globally, would be far easier and practical.
The first phase has a built up area of about 15000 square metres, which is steadily on the rise, and upon completion of the functional offices and manufacturing stations, will shoot up to above 37000 square meters. The estimated date for completion of this project is in 2023. In the near future, West will file DMFs for its newly constructed plant with the USFDA and Canadian Pharmaceutical Bureau.
Dr. Jay Shinde
No comments:
Post a Comment